Optimizing Outcome in Complex PCI
Organized by CVRF and Supported by Educational Grant from Abbott
Thursday, August 6 ~ Saturday, August 8
Moderator(s): Krishna Sudhir
| Why Stent Design Matters in ACS and Short DAPT (0:00:05 ~ 0:24:18) | Lecturer: Aloke V. Finn |
Moderator(s): Krishna Sudhir
| MLD MAX -Keyword for OCT Guided PCI (0:24:19 ~ 0:45:51) | Lecturer: Hyuck Jun Yoon |
Moderator(s): Nick West
| Physiologic Assessment of Coronary Artery Disease in Cath Lab; FFR, Non-Hyperemic Pressure Index, and Index for CMD (0:45:52 ~ 1:06:45) | Lecturer: Ki-Hyun Jeon |
OCT Decision Making Results
Organized by CVRF and Supported by Educational Grant from Abbott
Thursday, August 6 ~ Saturday, August 8
Moderator(s): Nick West
| LIGHTLAB STUDY INTRODUCED: Understanding Study Methodology and Background (00:00:00 ~ 00:15:47) | Lecturer: Nick West |
| LIGHTLAB STUDY RESULTS: Uncovering the Impact of an Algorithmic Approach to OCT-Guided PCI on Treatment Decision Making (00:15:48 ~ 00:37:10) | Lecturer: Kevin Croce |
| INTERPRETING LIGHTLAB RESULTS: What is the implication of This Data in Clinical Practice? (00:37:11 ~ 00:55:44) | Lecturer: Jason Wollmuth |
| DISCUSSION: Interpreting LIGHTLAB Study Results in an ASIA PACIFIC Context (00:55:45 ~ 01:20:51) |
Is MitraClip Being Surge for Mitral Regurgitation Treatment Option?
Organized by CVRF and Supported by Educational Grant from Abbott
Thursday, August 6 ~ Saturday, August 8
Moderator(s): Jung-Sun Kim
Panelist(s): Shunsuke Kubo
| Echo Guide MitraClip Procedure (00:01:25 ~ 00:19:51) | Lecturer: Dae-Hee Kim |
| MitraClip Case Presentation #1 (00:20:34 ~ 00:31:27) | Lecturer: Do-Yoon Kang |
| MitraClip Case Presentation #2 (00:32:30 ~ 00:43:57) | Lecturer: Sung-Jin Hong |
| Q & A (00:43:58 ~ 00:58:37) |
Advance Science for Life: HD IVUS
Organized by CVRF and Supported by Educational Grant from Boston Scientific
Thursday, August 6 ~ Saturday, August 8
| New Advances in Imaging with OPTICROSS HD 60MHz Imaging Catheter | Lecturer: Jung Ho Heo |
Advance Science for Life: Rotablator
Organized by CVRF and Supported by Educational Grant from Boston Scientific
Thursday, August 6 ~ Saturday, August 8
| 1. Calcified Coronary Stenosis Optimizing PCI with Rotablator 2. Rotational Atherectomy Complication Managment: StUCK BURR |
Lecturer: Pil Hyung Lee |
The New Era of Complex PCI
Organized by CVRF and Supported by Educational Grant from Medtronic Korea Ltd.
Thursday, August 6 ~ Saturday, August 8
| ONYX ONE Randomized Trial and ONYX ONE CLEAR Study : Evolution of Evidence for Abbreviated DAPT in High Bleeding Risk Patients | Lecturer: David E. Kandzari |
| Management of Patients with HBR Using Resolute Onyx in Real Practice | Lecturer: Hyo-Soo Kim |
| How Did I Treat My Patients with Telescope | Lecturer: Jun Ted Chong |
IN.PACT¢â Long- term Proven Clinical Outcome and Accurate Self-expandable Stent Entrust¢â
Organized by CVRF and Supported by Educational Grant from Medtronic Korea Ltd.
Thursday, August 6 ~ Saturday, August 8
| 4Y Outcome of Asian Population in IN.PACT DCB | Lecturer: Young-Guk Ko |
| Clinical Outcomes Comparison of All Drug Devices to Treat FP Disease | Lecturer: Su Hong Kim |
| Drug-Coated Balloon in Combination with Nitinol Stent Strategy for Peripheral Artery Disease | Lecturer: Sang-Su Lee |
Strategies to Optimize Management of ASCVD
Organized by CVRF and Supported by Educational Grant from Pfizer Upjohn Korea Ltd.
Thursday, August 6 ~ Saturday, August 8
Moderator(s): Hyeon-Cheol Gwon
| Opening | Speaker: Hyeon-Cheol Gwon |
| If it's All Just LDL -C Reduction, Shouldn¡¯t We Clarify Many Faces of Atorvastatin | Lecturer: Bum Joon Kim |
| LEGACY Effect : Navigating Importance of Early Treatment in HTN/DYS | Lecturer: Jong-Young Lee |
| Discussion & Closing | Speaker: Hyeon-Cheol Gwon |
The Lower, The Better with Evidence
Organized by CVRF and Supported by Educational Grant from Pfizer Upjohn Korea Ltd.
Thursday, August 6 ~ Saturday, August 8
| Opening | Speaker: Osung Kwon |
| Why is It Imperative to Consider Maximum Tolerable Statin as a First Treatment Option for ASCVD Patients | Lecturer: Osung Kwon |
| Individualizing Lipid Management : Selecting the Optimal Drug for the Right Patient | Lecturer: Do-Yoon Kang |
| Discussion | |
| Closing | Speaker: Do-Yoon Kang |
The SAPIEN 3 TAVR Advantage: Simple. Predictable. Proven
Organized by CVRF and Supported by Educational Grant from Edwards Lifesciences Korea Co., Ltd.
Thursday, August 6 ~ Saturday, August 8
Moderator(s): Seung-Jung Park, Alan C. Yeung
| Opening | Speaker: Seung-Jung Park |
| TAVR in the World with COVID-19 | Lecturer: Alan C. Yeung |
| How to Select Transcatheter Heart Valve in Low Risk Patients | Lecturer: Vinayak Bapat |
| Sapien 3 TAVI in Bicuspid Aortic Valve Patients | Lecturer: Jung-Min Ahn |
| Discussion & Closing | Speaker: Alan C. Yeung |
Efficacy & Safety of Ezetimibe/Statin Combination Therapy in Patients with Dyslipidemia
Organized by CVRF and Supported by Educational Grant from MSD KOREA
Thursday, August 6 ~ Saturday, August 8
| Efficacy & Safety of Ezetimibe/Statin Combination Therapy in Patients with Dyslipidemia | Lecturer: Ki Hoon Han |
Clinical Implementation of PCSK9 Inhibitor in Korea
Organized by CVRF and Supported by Educational Grant from Amgen Korea
Thursday, August 6 ~ Saturday, August 8
Moderator(s): Tae Hoon Ahn, Bum-Kee Hong
Panelist(s): Byeong-Keuk Kim, Sung Eun Kim
| Opening | Speaker: Tae Hoon Ahn |
| The Importance of Earlier and Lower LDL-C Reduction in ASCVD Patients | Lecturer: Byeong-Keuk Kim |
| PROFICIO : Advanced Lipid Management with Evolocumab | Lecturer: Sung Eun Kim |
| Discussion | |
| Closing | Speaker: Bum-Kee Hong |